Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 22 min ago
PreprintAll rights reservedbioRxiv

GDF3 is an endogenous antagonist of the ActE-ALK7/ACVR2 pathway in adipocytes

  • N. Kotikalapudi
  • D. Ramachandran
  • E. Y. Zhou
  • J. A. Howard
  • C. J. Vieira
  • W.-A. Chen
  • S. Hsu
  • K. C. Shin
  • S. Naz
  • Z. G. Jiang
  • J. M. Mercader
  • T. B. Thompson
4 more authors
  • S. E. Flaherty
  • P. M. Titchenell
  • H. F. Kramer
  • A. S. Banks1
  1. 1Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA
Read full textPDFDOICite

Related

  1. Discovery of a Peripherally Directed CB1 Receptor Antagonist That Restores Insulin Signaling in Adipocytes
    Jhonny Azuaje, Rubén Prieto-Díaz, Claudia Gioé-Gallo +17
    ACS OmegaPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyCrossrefDOAJPMC
  2. Minor role of endogenous opioids for acute pain regulation in humans: a systematic review and meta-analysis of placebo-controlled antagonist studies
    Isabell M. Meier, Martin Trøstheim, Eira N. Jensen +4
    PainPeer-reviewedCC BY-NC-ND 4.0Full textPhysiologyPMC
  3. In Vitro Model of Cytokine-Induced Inflammatory 3T3-L1 Adipocytes Mimicking Obesity
    Lucille Cartier, Rémi Fournet, Manon de Boni +4
    Bio-protocolPeer-reviewedLicence not stated1 citedEpidemiology & public healthHAL
  4. Acute loss of PLIN5 in brown adipocytes reveals its indispensable role in maintaining mitochondrial function and cold tolerance
    Violeta I. Gallardo Montejano, Chaofeng Yang, Hannah Hurtado +1
    Journal of Biological ChemistryPeer-reviewedCC BY 4.0PhysiologyCrossref
  5. Human bone marrow adipocytes drive prostate cancer bone metastasis progression via lipid-mediated induction of Angiopoietinlike 4
    Marine Hernandez, Sauyeun Shin, David Rengel +9
    HALPreprintPublisher termsFull text1 citedOncologyHAL

Cite

BibTeXRIS
BibTeX
@misc{kotikalapudi2026gdf3,
  title = {{GDF3 is an endogenous antagonist of the ActE-ALK7/ACVR2 pathway in adipocytes}},
  author = {N. Kotikalapudi and D. Ramachandran and E. Y. Zhou and J. A. Howard and C. J. Vieira and W.-A. Chen and S. Hsu and K. C. Shin and S. Naz and Z. G. Jiang and J. M. Mercader and T. B. Thompson and S. E. Flaherty and P. M. Titchenell and H. F. Kramer and A. S. Banks},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.18.752693},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.18.752693v1},
}
RIS
TY  - UNPB
TI  - GDF3 is an endogenous antagonist of the ActE-ALK7/ACVR2 pathway in adipocytes
AU  - N. Kotikalapudi
AU  - D. Ramachandran
AU  - E. Y. Zhou
AU  - J. A. Howard
AU  - C. J. Vieira
AU  - W.-A. Chen
AU  - S. Hsu
AU  - K. C. Shin
AU  - S. Naz
AU  - Z. G. Jiang
AU  - J. M. Mercader
AU  - T. B. Thompson
AU  - S. E. Flaherty
AU  - P. M. Titchenell
AU  - H. F. Kramer
AU  - A. S. Banks
PY  - 2026
DA  - 2026/09/18
PB  - bioRxiv
DO  - 10.64898/2026.09.18.752693
UR  - https://www.biorxiv.org/content/10.64898/2026.09.18.752693v1
ER  -